Faxitron Bioptics
Faxitron Bioptics designs and sells digital specimen radiography systems for hospital pathology labs and breast health centers, using CMOS detector technology to image tissue samples. Acquired by Hologic in 2017, it now operates as a product line within Hologic's breast health portfolio.
- Company typePublic
- Founded1993
- HeadquartersTucson, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Faxitron Bioptics does
Faxitron Bioptics, founded in 1993 and headquartered in Tucson, Arizona, is a medical device company specializing in digital specimen radiography systems for pathology laboratories. The company's flagship product, the Faxitron Path Specimen Radiography System (also marketed as PathVision), uses a large-format 23 x 29 cm CMOS detector combined with a wide 20-100kV energy range and up to 6X geometric magnification to deliver high-resolution imaging of pathology specimens — including breast tissue slides, intact mastectomies, bones, and fetal remains. The system features automatic exposure control (AEC) and point-of-care placement design for one-button operation, targeting reduced re-cuts and faster reporting in pathology workflows.
Since its acquisition by Hologic, Inc. (NASDAQ: HOLX) in 2017, Faxitron Bioptics has operated as a product line within Hologic's breast health portfolio rather than as an independent entity. The product is sold as capital equipment to hospital pathology labs, breast health centers, and medical research laboratories through Hologic's enterprise direct sales organization, with US customers able to order through Hologic's iStore online platform. Revenue mechanics are based on one-time hardware sales, complemented by service and support contracts, with marketing handled primarily through Hologic's corporate website, datasheets, training materials, and presence at medical conferences.
The company's 51-100 employee headcount, combined with Hologic's global distribution footprint spanning North America, Europe, and Asia Pacific, positions Faxitron as a niche but distribution-rich player in the digital specimen radiography niche, with particular strength in breast pathology applications.
Faxitron Bioptics firmographics
Firmographics- Name
- Faxitron Bioptics
- Legal name
- Hologic, Inc.
- Website
- https://faxitron.com
- Company type
- Public
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Faxitron Bioptics designs and sells digital specimen radiography systems for hospital pathology labs and breast health centers, using CMOS detector technology to image tissue samples. Acquired by Hologic in 2017, it now operates as a product line within Hologic's breast health portfolio.
- Ownership category
- akta.pro rank
Faxitron Bioptics industry classification
Industry- Product category
- Digital Specimen Radiography Equipment
- NAICS
- Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Mammography & Breast Imaging Systems (HLAHABAF)
- akta.pro secondary industry
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
Keywords
Where Faxitron Bioptics is headquartered
LocationHeadquarters
- HQ city
- Tucson
- HQ country
- United States
- HQ region
- North America
Markets served
Faxitron Bioptics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations
Revenue model
- Medical Device Hardware Sales: One-time capital equipment sales of Faxitron Path specimen radiography systems to hospital pathology departments and laboratory settings. Revenue generated from initial hardware purchase, with potential for service and support contracts.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Faxitron Bioptics product offering
Product offeringCore offering
Faxitron Bioptics designs, manufactures, and sells the Faxitron Path Specimen Radiography System (also marketed as PathVision), a digital pathology imaging device used by hospital pathology labs and breast health centers. The system provides high-resolution digital imaging of surgical and biopsy specimens—including breast tissue, mastectomies, bones, and fetal remains—using a large-format CMOS detector with up to 6X geometric magnification and automatic exposure control for point-of-care use.
Product overview
Faxitron Bioptics, now part of Hologic, offers specimen radiography and digital pathology solutions. The core product is the Faxitron® Path Specimen Radiography System (also known as PathVision™), which provides high-resolution imaging for pathology specimens with up to 6X geometric magnification and automatic exposure control. This integrates with the FaxitronPath® Digital Pathology System for complete digital pathology workflow solutions, enabling pathologists to achieve greater efficiency and exceptional patient care through immediate access to imaging and reporting at the point of care.
Differentiator
Problem solved
Functional benefit
Products and services
- Faxitron Path Specimen Radiography System A specimen radiography system for hospital pathology departments providing immediate high-resolution digital imaging of tissue samples. Features a 23 x 29 cm CMOS detector, up to 6X geometric magnification, wide 20-100kV energy range, one-button operation with Automatic Exposure Control, and accommodates breast tissue slides, intact mastectomies, bones, and fetal remains.
Quantifiable outcome
- Up to 6X geometric magnification for detection of smallest calcifications
- +2 more outcomes
Companies that use Faxitron Bioptics
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Faxitron Bioptics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Faxitron Bioptics partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
Faxitron Bioptics competitors and assessment
Company assessmentBroad incumbents
- Philips Healthcare: Imaging incumbent serving hospital radiology departments with mammography and diagnostic X-ray systems; competes with Faxitron Path for capital equipment share within the same hospital networks.
- GE HealthCare: Global imaging incumbent offering mammography, ultrasound and digital radiography equipment to the same hospital radiology and pathology buyers. Overlaps with Faxitron Path in breast imaging workflows at the hospital system level.
- Hologic: Parent company and broader women's-health imaging incumbent. Hologic's mammography, biopsy and breast surgery franchises share the same hospital pathology and breast center buyers that Faxitron Path serves.
- Roche Digital Pathology (Ventana): Digital pathology and tissue diagnostics franchise of Roche serving hospital pathology labs with whole-slide imaging and companion diagnostic workflows that interface with specimen imaging.
- Leica Biosystems (Danaher): Major pathology workflow vendor (whole-slide imaging, tissue processors, staining) that overlaps with Faxitron Path at the pathology department level and competes for the digital pathology budget.
- Fujifilm Healthcare: Mammography and X-ray imaging vendor with breast health and digital radiography offerings that compete for the same hospital capital budgets as Faxitron Path.
- Siemens Healthineers: Broad-line imaging and diagnostics vendor with mammography and X-ray portfolios targeting the same hospital procurement and radiology-pathology stakeholders as Faxitron Path.
Emerging players
- Hamamatsu Photonics: Manufacturer of high-resolution digital slide scanners and detectors used in pathology imaging; comparable to Faxitron Path at the imaging-sensor and digital pathology workflow layer.
- 3DHISTECH: Digital pathology scanner and software vendor serving hospital and research pathology labs; competes with FaxitronPath digital pathology software workflow around whole-slide imaging and case management.
Direct peers
- Kubtec: Closest direct competitor in cabinet specimen radiography for breast and pathology use. Kubtec's XPERT systems compete head-to-head with the Faxitron Path on field of view, magnification and digital imaging of excised tissue specimens.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Faxitron Bioptics social profiles
Digital presenceFaxitron Bioptics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Faxitron Bioptics leadership team
Management profileNumber of profiles
Profiles1 record
Faxitron Bioptics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Faxitron Bioptics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Faxitron Bioptics
What does Faxitron Bioptics do?
Faxitron Bioptics designs, manufactures, and sells the Faxitron Path Specimen Radiography System (also marketed as PathVision), a digital pathology imaging device used by hospital pathology labs and breast health centers. The system provides high-resolution digital imaging of surgical and biopsy specimens—including breast tissue, mastectomies, bones, and fetal remains—using a large-format CMOS detector with up to 6X geometric magnification and automatic exposure control for point-of-care use.
Is Faxitron Bioptics a public or private company?
Faxitron Bioptics is a public company. It is classified as corporate owned and is currently operating.
When was Faxitron Bioptics founded?
Faxitron Bioptics was founded in 1993. It employs 51 to 100 people.
Where is Faxitron Bioptics based?
Faxitron Bioptics is headquartered in Tucson, United States, in the North America region.
How does Faxitron Bioptics make money?
One revenue line is on record: medical Device Hardware Sales.
Who are Faxitron Bioptics's main competitors?
Broad incumbents on record are Philips Healthcare, GE HealthCare, Hologic, Roche Digital Pathology (Ventana), Leica Biosystems (Danaher), Fujifilm Healthcare and Siemens Healthineers. Emerging players are Hamamatsu Photonics and 3DHISTECH. Kubtec is listed as a direct peer.
Does Faxitron Bioptics have an API?
No public API is recorded for Faxitron Bioptics.
What industry is Faxitron Bioptics in?
Faxitron Bioptics's product category is Digital Specimen Radiography Equipment. Its primary akta.pro industry code is HLAHABAF, Mammography & Breast Imaging Systems, with a secondary code of HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems. Its NAICS code is 334517 and its SIC code is 3841.